ArticleCommunity mental health journal2026
Anti-Stigma Interventions to Reduce Schizophrenia-Related Stigma Among Mental Health Professionals: A Systematic Review.
Article in Community mental health journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Schizophrenia is one of the most stigmatized mental disorders, hindering access to treatment and social inclusion. Stigma exists in society and among mental health professionals, where negative attitudes can erode patients' trust and harm therapeutic relationships. Anti-stigma programs seek to reduce prejudice and foster empathy toward those affected. This paper evaluates the effectiveness of anti-stigma programs specifically targeting mental health professionals. The aim is to identify the key elements of successful interventions and derive practical recommendations to improve therapeutic relationships and promote the psychosocial integration of patients with schizophrenia. A systematic literature review was conducted using scientific databases, including PubMed, PsycINFO, Web of Science, and Google Scholar. Both quantitative and qualitative primary studies were included in the analysis, while relevant systematic and scoping reviews were used as contextual background literature. A total of 14 relevant studies were identified and analyzed. The analysis revealed that anti-stigma programs incorporating psychosocial models and direct patient contact were particularly effective in reducing stigmatizing attitudes. Most of the 14 included studies reported significant improvements in mental health professionals's attitudes toward individuals with schizophrenia. Long-term, interactive, and culturally sensitive interventions were found to yield the most sustainable changes. In contrast, purely educational programs sometimes led to unintended negative effects by reinforcing existing stereotypes. The findings highlight the importance of carefully designing anti-stigma programs to ensure their effectiveness. Psychosocial approaches, which focus on the person behind the diagnosis, are particularly suitable for fostering empathy and trust in therapeutic relationships. Additionally, interventions must be tailored to the specific needs of mental health professionals and adapted to the cultural context to avoid reinforcing biases. The findings demonstrate that anti-stigma programs for mental health professionals can significantly reduce prejudices and improve therapeutic relationships. Interactive, recovery-oriented approaches that involve direct patient contact are particularly effective in achieving sustainable changes in attitudes and behavior. The implementation of such programs can strengthen patients' trust in psychiatric care and contribute to a more humanistic practice in mental health services.
Indexed as
Identifiers
42405992What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.